Building Supply Chain Resilience: The Biden Administration’s 100-Day Supply Chain Review Findings on Pharmaceuticals and APIs

By |2021-06-24T11:32:22-04:0006/24/2021|

On February 24, 2021, President Biden signed an Executive Order on America’s Supply Chains (EO) as a step toward building more secure, robust and resilient supply chains. The EO initiated a 100-Day Supply Chain Review, which detailed an assessment of the strengths and weaknesses of the domestic supply chains for four key product areas, one of which included a review of pharmaceuticals and [...]

The CARES Act & Your Supply Chain: What You Need to Know

By |2021-06-24T11:34:46-04:0006/24/2021|

Jeremy Friedler, senior consultant, and Rashi Gupta, consultant, focus on biotechnology and pharmaceutical operations at Converge Consulting. The COVID-19 pandemic and resulting economic crisis exposed the vulnerabilities of both domestic and global supply chains across multiple industries. Given the complexity and far-reaching global nature of their supply chains, pharmaceutical and biotechnology companies were [...]

Inaugural Meeting of the Supply Chain Working Group

By |2021-03-26T10:56:22-04:0011/19/2020|

December 17, 2020 @ 12:00 – 1:00p Join the Supply Chain Working Group Sign up as a member of the Life Sciences Supply Chain Working Group by registering for this inaugural event. The group currently has over 30 members who are supply chain executives at the Director level or above. The meeting program [...]

Stage-Appropriate Quality Systems

By |2020-10-22T12:18:12-04:0010/22/2020|

Stage-Appropriate Quality Systems development comes up directly or indirectly in essentially all our client work. Quality Management is essential for emerging biopharma companies in particular, who face significant technical, scientific, clinical, and operational uncertainties. There is always a question of how much, and how soon? We see some companies 'build for success' who [...]

Improving Demand & Supply Planning for Emerging Life Science Companies

By |2020-09-25T09:09:06-04:0009/24/2020|

Improving Demand & Supply Planning for Emerging Life Science Companies Todd Applebaum, Managing Director Our Demand & Supply Planning Maturity Model aligns key aspects of the planning process to each company's lifecycle. Improving demand and supply planning is crucial for Life Science companies. This is especially valuable when dealing with [...]

Go to Top